PCM
ZBH icon

Prelude Capital Management’s Zimmer Biomet ZBH Stock Holding History

Prelude Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,400
Closed -$1.06M – 1432
2025
Q1 		$1.06M Sell
9,400
-5,334
-36% -$571K 0.08% 297
2024
Q4 		$1.56M Buy
+14,734
New +$1.58M 0.1% 241
2024
Q2 		– Sell
-3,644
Closed -$481K – 1547
2024
Q1 		$481K Buy
+3,644
New +$455K 0.03% 653
2023
Q4 		– Sell
-5,156
Closed -$579K – 1395
2023
Q3 		$579K Buy
+5,156
New +$655K 0.04% 424
2023
Q1 		– Sell
-5,537
Closed -$706K – 1500
2022
Q4 		$706K Buy
5,537
+1,508
+37% +$175K 0.04% 457
2022
Q3 		$421K Buy
4,029
+1,396
+53% +$153K 0.02% 716
2022
Q2 		$277K Sell
2,633
-4,808
-65% -$570K 0.01% 1113
2022
Q1 		$952K Buy
+7,441
New +$897K 0.03% 614
2020
Q3 		– Sell
-5,637
Closed -$653K – 2441
2020
Q2 		$653K Buy
+5,637
New +$650K 0.04% 407
2020
Q1 		– Sell
-412
Closed -$60K – 2118
2019
Q4 		$60K Sell
412
-5,576
-93% -$770K ﹤0.01% 1280
2019
Q3 		$798K Buy
+5,988
New +$774K 0.04% 400
2016
Q4 		– Sell
-2,849
Closed -$360K – 1816
2016
Q3 		$360K Buy
+2,849
New +$352K 0.04% 379
2015
Q4 		– Sell
-8,979
Closed -$819K – 1719
2015
Q3 		$819K Sell
8,979
-466
-5% -$46.7K 0.12% 204
2015
Q2 		$1M Sell
9,445
-1,164
-11% -$129K 0.14% 178
2015
Q1 		$1.21M Buy
+10,609
New +$1.21M 0.17% 160
2014
Q4 		– Sell
-1,673
Closed -$163K – 2188
2014
Q3 		$163K Buy
1,673
+1,272
+317% +$125K 0.02% 800
2014
Q2 		$40K Sell
401
-505
-56% -$49.3K 0.01% 1475
2014
Q1 		$83K Buy
+906
New +$83.5K 0.01% 1098

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Prelude Capital Management's ZBH Position: Q2 2025 in Review

Prelude Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 9,400 shares — an estimated $1.06M sold.

Prelude Capital Management first reported a position in ZBH in Q1 2014 and held it in 18 quarters. The position peaked at $1.56M in Q4 2024. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • Prelude Capital Management reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • Prelude Capital Management sold 9,400 Zimmer Biomet shares in Q2 2025, an estimated $1.06M.
  • Prelude Capital Management first reported a position in Zimmer Biomet in Q1 2014 and held it in 18 quarters.
  • Prelude Capital Management's Zimmer Biomet position peaked at $1.56M in Q4 2024.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.